Breaking News

You are here » Indian-Commodity  :  Corporate  :  CRISIL upgrades rating of Alembic Pharma's long-term bank facilities

24-Jul2017

CRISIL upgrades rating of Alembic Pharma's long-term bank facilities

Credit rating agency, CRISIL has upgraded the rating of long-term bank facilities of Alembic Pharmaceuticals to 'AA+/Stable' from 'AA/Positive' worth Rs 315 crore limit of fund/non-fund based facilities.

Moreover, the rating agency has reaffirmed the rating of the company's short-term debt including Commercial Paper to 'A1+' worth Rs 200 crore.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.


Related News

View all news

GMR Infrastructure's arm launches Airport Radio in Hyderabad

GMR Infrastructure's subsidiary -- GMR Hyderabad International Airport (GHIAL) has launched South India's first Airport Radio under its signature '#PassengerIsPrime' programme at Rajiv Gandhi International......

CRISIL reports 30% rise in Q3 consolidated net profit

CRISIL has reported results for third quarter ended September 30, 2018.The company has reported a rise of 18% in its net profit of Rs 65.29 crore for the quarter under review as compared to Rs 55.33 crore......

Genesys initiates aerial survey for Jaipur's 3D city model project

Genesys International Corporation has started the mapping of the city of Jaipur using an array of latest technologies to create the most accurate and realistic 3D models of each and every structure in......

Top News

View all news

Hero MotoCorp achieves best ever sales performance in Q2 FY19

Hero MotoCorp has achieved its best-ever sales performance for the second quarter of any financial year, selling 21,34,051 units of two-wheelers in Q2 FY19.For the period April-September 2018, Hero MotoCorp......

Mahindra CIE Automotive reports 74% rise in Q3 net profit

Mahindra CIE Automotive has reported results for third quarter ended September 30, 2018.The company has reported 73.80% rise in its net profit at Rs 42.58 crore for the quarter under review as compared......

Infosys crosses $2 billion large deal signings in Q2 FY19

Infosys has crossed $2 billion large deal signings in Q2 FY19. Besides, the company's digital revenues stood at $905 million in Q2 FY19 (31.0% of total revenues), year-on-year growth of 33.5% and sequential......